Access

Article


Nature Medicine 14, 144 - 153 (2008)
Published online: 27 January 2008 | doi:10.1038/nm1717

Dual role of proapoptotic BAD in insulin secretion and beta cell survival

Nika N Danial1,2,3, Loren D Walensky2,3,4,5, Chen-Yu Zhang6, Cheol Soo Choi7,8, Jill K Fisher1,2,3, Anthony J A Molina9, Sandeep Robert Datta10,13, Kenneth L Pitter2,3,4,5, Gregory H Bird2,3,4,5, Jakob D Wikstrom9, Jude T Deeney11, Kirsten Robertson1,2,3, Joel Morash2,3,4,5, Ameya Kulkarni7,8, Susanne Neschen7,8, Sheene Kim7,8, Michael E Greenberg10, Barbara E Corkey11, Orian S Shirihai9, Gerald I Shulman7,8, Bradford B Lowell12 & Stanley J Korsmeyer1,7


The proapoptotic BCL-2 family member BAD resides in a glucokinase-containing complex that regulates glucose-driven mitochondrial respiration. Here, we present genetic evidence of a physiologic role for BAD in glucose-stimulated insulin secretion by beta cells. This novel function of BAD is specifically dependent upon the phosphorylation of its BH3 sequence, previously defined as an essential death domain. We highlight the pharmacologic relevance of phosphorylated BAD BH3 by using cell-permeable, hydrocarbon-stapled BAD BH3 helices that target glucokinase, restore glucose-driven mitochondrial respiration and correct the insulin secretory response in Bad-deficient islets. Our studies uncover an alternative target and function for the BAD BH3 domain and emphasize the therapeutic potential of phosphorylated BAD BH3 mimetics in selectively restoring beta cell function. Furthermore, we show that BAD regulates the physiologic adaptation of beta cell mass during high-fat feeding. Our findings provide genetic proof of the bifunctional activities of BAD in both beta cell survival and insulin secretion.


MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Cell biology Metabolism meets death

Nature News and Views (21 Aug 2003)